Angiotensin Receptor-Nebrilysin inhibition in Patients Hospitalized With Acute Decompensated Heart Failure: Primary Results of the PIONEER-HF Randomized Controlled Trial
Publication
, Conference
Velazquez, EJ; Morrow, DA; DeVore, AD; Duffy, CI; Ambrosy, AP; McCague, K; Rocha, RA; Braunwald, E
Published in: CIRCULATION
December 18, 2018
Duke Scholars
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
December 18, 2018
Volume
138
Issue
25
Start / End Page
E760 / E761
Location
Chicago, IL
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
Scientific Sessions of the American-Heart-Association (AHA) / Resuscitation Science Symposium
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Velazquez, E. J., Morrow, D. A., DeVore, A. D., Duffy, C. I., Ambrosy, A. P., McCague, K., … Braunwald, E. (2018). Angiotensin Receptor-Nebrilysin inhibition in Patients Hospitalized With Acute Decompensated Heart Failure: Primary Results of the PIONEER-HF Randomized Controlled Trial. In CIRCULATION (Vol. 138, pp. E760–E761). Chicago, IL: LIPPINCOTT WILLIAMS & WILKINS.
Velazquez, Eric J., David A. Morrow, Adam D. DeVore, Carol I. Duffy, Andrew P. Ambrosy, Kevin McCague, Ricardo A. Rocha, and Eugene Braunwald. “Angiotensin Receptor-Nebrilysin inhibition in Patients Hospitalized With Acute Decompensated Heart Failure: Primary Results of the PIONEER-HF Randomized Controlled Trial.” In CIRCULATION, 138:E760–61. LIPPINCOTT WILLIAMS & WILKINS, 2018.
Velazquez EJ, Morrow DA, DeVore AD, Duffy CI, Ambrosy AP, McCague K, et al. Angiotensin Receptor-Nebrilysin inhibition in Patients Hospitalized With Acute Decompensated Heart Failure: Primary Results of the PIONEER-HF Randomized Controlled Trial. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2018. p. E760–1.
Velazquez, Eric J., et al. “Angiotensin Receptor-Nebrilysin inhibition in Patients Hospitalized With Acute Decompensated Heart Failure: Primary Results of the PIONEER-HF Randomized Controlled Trial.” CIRCULATION, vol. 138, no. 25, LIPPINCOTT WILLIAMS & WILKINS, 2018, pp. E760–61.
Velazquez EJ, Morrow DA, DeVore AD, Duffy CI, Ambrosy AP, McCague K, Rocha RA, Braunwald E. Angiotensin Receptor-Nebrilysin inhibition in Patients Hospitalized With Acute Decompensated Heart Failure: Primary Results of the PIONEER-HF Randomized Controlled Trial. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2018. p. E760–E761.
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
December 18, 2018
Volume
138
Issue
25
Start / End Page
E760 / E761
Location
Chicago, IL
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
Scientific Sessions of the American-Heart-Association (AHA) / Resuscitation Science Symposium
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology